Antiaging Quantum Living Inc.
AAQL
$0.988
$0.676216.67%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 529.80K | 381.60K | 208.40K | 7.50K | 8.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 529.80K | 381.60K | 208.40K | 7.50K | 8.70K |
| Cost of Revenue | 19.80K | 15.40K | 1.00K | 800.00 | 800.00 |
| Gross Profit | 510.00K | 366.20K | 207.40K | 6.70K | 7.90K |
| SG&A Expenses | 1.38M | 1.14M | 804.60K | 419.70K | 166.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.40M | 1.15M | 805.60K | 420.50K | 167.10K |
| Operating Income | -872.30K | -770.60K | -597.20K | -413.00K | -158.40K |
| Income Before Tax | -802.60K | -770.50K | -597.20K | -413.00K | -158.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.80 | -0.77 | -0.60 | -0.41 | -0.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -802.60K | -770.50K | -597.20K | -413.00K | -158.40K |
| EBIT | -872.30K | -770.60K | -597.20K | -413.00K | -158.40K |
| EBITDA | -757.50K | -691.90K | -569.90K | -406.00K | -158.10K |
| EPS Basic | -0.03 | -0.03 | -0.02 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 119.94M | 119.94M | 119.94M | 119.98M | 119.98M |
| Average Diluted Shares Outstanding | 119.94M | 119.94M | 119.94M | 119.98M | 119.98M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
